{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-050061","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2022-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.749020+00:00","generated_at":"2026-06-23T22:19:03.991328+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Hoth Therapeutics lowers shareholder meeting quorum to one-third, permits board bylaw changes by written consent","bullets":["Board approved amendment reducing quorum for shareholder meetings from majority to one-third of outstanding voting stock.","Amendment also allows board to adopt, amend, or repeal bylaws by written consent without a meeting.","Changes made to Article II Section 2.6 and Article X Section 10.1 of Amended and Restated Bylaws.","Effective as of August 19, 2022; full text filed as Exhibit 3.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-050061","json":"https://secwatch.observer/filing/0001213900-22-050061.json","markdown":"https://secwatch.observer/filing/0001213900-22-050061.md","text":"https://secwatch.observer/filing/0001213900-22-050061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390022050061/0001213900-22-050061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390022050061/ea164742-8k_hoththera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T22:19:03.991328+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}